Predict your next investment

Angel Investor (Group)
cambridgeangels.angelgroups.net

See what CB Insights has to offer

Investments

77

Portfolio Exits

9

About Cambridge Angels

The Cambridge Angels is an angel investment group comprised of a group of high-net worth investors primarily in technology and bio-technology. Cambridge Angels investors include John Taysom, whose early stage internet investments include Advertising.com, Yahoo!, Forbes.com and infoseek and Andy Phillipps, formerly CEO and co-founder of Active Hotels. Other Cambridge Angels include Robert Brady, founder of Brady plc, a software solutions business. John Yeomans, a director of First Capital is also a Cambridge Angel and London Business School E100 member.

Cambridge Angels Headquarter Location

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Cambridge Angels News

Angel Academe invests in FeedForward

Jul 19, 2022

Angel Academe have led an investment round in FeedForward, alongside Cambridge Angels and other individual investors. Co-founded by CEO Lydia Gregory (pictured), CSO Kevin Webster and CTO Jason Storey, FeedForward uses AI to release vastly more value from the content […] The post Angel Academe invests in FeedForward appeared first on UK Business Angels Association.

Cambridge Angels Investments

77 Investments

Cambridge Angels has made 77 investments. Their latest investment was in Porotech as part of their Seed VC - II on June 6, 2021.

CBI Logo

Cambridge Angels Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/24/2021

Seed VC - II

Porotech

$4.18M

No

4

3/15/2021

Series B

Focal Point Positioning

$8.35M

No

2

3/15/2021

Seed VC

Antiverse

$1.95M

Yes

8

2/18/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/20/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/24/2021

3/15/2021

3/15/2021

2/18/2021

1/20/2021

Round

Seed VC - II

Series B

Seed VC

Series A

Series A

Company

Porotech

Focal Point Positioning

Antiverse

Subscribe to see more

Subscribe to see more

Amount

$4.18M

$8.35M

$1.95M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

2

8

10

10

Cambridge Angels Portfolio Exits

9 Portfolio Exits

Cambridge Angels has 9 portfolio exits. Their latest portfolio exit was ThirdEye Labs on November 10, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/10/2021

Acquired

$99M

2

3/4/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/12/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/28/2018

Corporate Majority

Subscribe to see more

$99M

Subscribe to see more

10

9/23/2014

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/10/2021

3/4/2021

12/12/2019

6/28/2018

9/23/2014

Exit

Acquired

Acquired

Acquired

Corporate Majority

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.